ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 134679 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 134679; 2) Community: the network communities that were significantly associated with the response to NSC 134679; 3) Molecule: the relationships between components within communities and NSC 134679; 4) MDR: the compounds that were significantly associated with the NSC 134679.

NSC Compound Enrichment Correlation
NSC 112846 N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid 0.00770426557728501 0.63006402
NSC 301477 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-4-O-methyl-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- 0.00770426557728506 0.62888837
NSC 343499 CI-921: amsacrine derivative 0.00770426557728506 0.60851105
NSC 4280 2,9-Dimethylphenanthroline 0.00770426557728506 0.15452257
NSC 633497 Null 0.00770426557728506 0.10820198
NSC 648114 ANTINEOPLASTIC-D648114 0.00770426557728506 0.60492533
NSC 663337 Null 0.00770426557728506 0.2394711
NSC 682298 Camptothecin Derivative 0.00770426557728506 0.73423068
NSC 697194 Decanediamide, N,N'-bis[2-(2-hydroxy-1-naphthalenyl)- 5-(3,4-dimethoxyphenyl)methylene]-4-oxo- 3-thiazolidinyl]- 0.00770426557728506 0.38122662
NSC 708419 Null 0.00770426557728506 0.26167894
Total:63  Current:14    [First] [Prev] [Next] [Last]